These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 1284685)

  • 41. Filtration of buffy coat free red cell concentrates in additive solution.
    Dietrich G; Dietrich K; Kretschmer V; Eckle R
    Infusionsther Transfusionsmed; 1992 Jun; 19(3):151-6. PubMed ID: 1498559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pooled platelet concentrates: an alternative to single donor apheresis platelets?
    Pietersz RN
    Transfus Apher Sci; 2009 Oct; 41(2):115-9. PubMed ID: 19716340
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quality of plasma separated from (buffy coat + plasma). An alternative way of blood processing.
    Rácz Z; Baróti C; Hidvégi T; Skopál J; Thék M
    Acta Haematol Pol; 1994; 25(1):47-53. PubMed ID: 8209614
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production.
    Levin E; Culibrk B; Gyöngyössy-Issa MI; Weiss S; Scammell K; LeFresne W; Jenkins C; Devine DV
    Transfusion; 2008 Nov; 48(11):2331-7. PubMed ID: 18631169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Separation of centrifuged whole blood and pooled buffy coats using the new CompoMat G5: 3 years experience.
    Bontekoe IJ; van der Meer PF; Mast G; de Korte D
    Vox Sang; 2014 Aug; 107(2):140-7. PubMed ID: 24602034
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates.
    Edvardsen L; Taaning E; Dreier B; Christensen LD; Mynster T; Nielsen HJ
    Am J Hematol; 2001 Jul; 67(3):157-62. PubMed ID: 11391711
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Comparison of the Haemonetics V50, Fenwal CS 3000 and IBM 2997 blood separators].
    Storek J; Vítek A; Sejkorová J; Kobylka P
    Cas Lek Cesk; 1989 Apr; 128(18):562-5. PubMed ID: 2736598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Platelet concentrates from buffy coats: improved conditions for preparation and evaluation in routine clinical use.
    Rebulla P; Bertolini F; Porretti L; Marangoni F; Smacchia C; Marconi M; Riccardi D; Sirelson V; Pappalettera M; Sirchia G
    Transfus Sci; 1993 Jan; 14(1):41-6. PubMed ID: 10148312
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Comparative evaluation of 3 leukocyte filters for thrombocyte concentrates].
    Reiser M; Kádár JG; Borberg H
    Beitr Infusionsther; 1991; 28():216-9. PubMed ID: 1725623
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Quality of thrombocyte preparations from buffy coat or platelet-rich plasma].
    Bux J; Müller K; Misterek J; Mueller-Eckhardt C
    Beitr Infusionsther; 1990; 26():99-102. PubMed ID: 1703912
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [In-line-filtration of erythrocyte concentrates using the Leukotrap-RC system].
    Richter E; Matthes G; Tofoté U; Rath E
    Beitr Infusionsther Transfusionsmed; 1994; 32():29-31. PubMed ID: 9480110
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [In-line leukocyte depletion ov thrombocytapheresis concentrates with the Fresenius-AS-104 cell separator].
    Zeiler T; Kretschmer V
    Beitr Infusionsther Transfusionsmed; 1997; 34():110-3. PubMed ID: 9417333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Results with new software for plateletpheresis systems.
    Moog R; Müller N
    Transfus Sci; 1994 Sep; 15(3):313-7. PubMed ID: 10155548
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Paired comparison of platelet concentrates prepared from platelet-rich plasma and buffy coats using a new technique with 111In and 51Cr.
    Keegan T; Heaton A; Holme S; Owens M; Nelson E; Carmen R
    Transfusion; 1992 Feb; 32(2):113-20. PubMed ID: 1542917
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variable leukocyte composition of red blood cell concentrates prepared in top-bottom systems: possible implications for pre-transplant blood transfusion.
    Weinreich SS; Remmerswaal EB; Laport R; van Rhenen DJ; Rombout-Sastrienkova E; Smit Sibinga CT; Vrielink H; Boog CJ
    Vox Sang; 2000; 79(2):83-6. PubMed ID: 11054045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation.
    Everts PA; Hoffmann J; Weibrich G; Mahoney CB; Schönberger JP; van Zundert A; Knape JT
    Transfus Med; 2006 Oct; 16(5):363-8. PubMed ID: 16999760
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days.
    Moog R; Fröhlich A; Mayaudon V; Lin L
    J Clin Apher; 2004; 19(4):185-91. PubMed ID: 15597347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Efficacy of 2 different leukocyte filters for erythrocyte concentrates].
    Barth A; Passerini M; Oppliger R; Spycher M; Nydegger U
    Schweiz Med Wochenschr; 1993 Jun; 123(22):1160-4. PubMed ID: 8322051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlation of platelet concentration in platelet-rich plasma to the extraction method, age, sex, and platelet count of the donor.
    Weibrich G; Kleis WK; Kunz-Kostomanolakis M; Loos AH; Wagner W
    Int J Oral Maxillofac Implants; 2001; 16(5):693-9. PubMed ID: 11669252
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Evaluation of platelet quality obtained using conventional methods or from buffy-coat and stored at room temperature].
    Dzieciatkowska A; Fuskiewicz M; Ziemba-Zółowska B; Sabliński J
    Acta Haematol Pol; 1994; 25(2):135-43. PubMed ID: 8067184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.